Alcon is a global leader in eye care, developing and manufacturing innovative devices and pharmaceuticals to treat eye conditions. It operates in two segments — Surgical and Vision Care — and sells products in around 70 countries. Alcon was spun off from Novartis as an independent company in 2019.